Filspari and Jardiance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Filspari (sparsentan) and Jardiance (empagliflozin). Common drug interactions include migraine among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Filspari and Jardiance. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Filspari?

Filspari has active ingredients of sparsentan. eHealthMe is studying from 1,185 Filspari users. Check the latest studies of Filspari.

What is Jardiance?

Jardiance has active ingredients of empagliflozin. It is often used in hyperglycemia. eHealthMe is studying from 44,460 Jardiance users. Check the latest studies of Jardiance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

16 people who take Filspari and Jardiance together, and have interactions are studied.

Filspari and Jardiance drug interactions.

What are the common drug interactions of Filspari and Jardiance, by gender? *:

female:

  1. Migraine (headache)
  2. Fatigue (feeling of tiredness)
  3. Decreased appetite
  4. Headache (pain in head)
  5. Nervousness
  6. Poor quality sleep
  7. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  8. Glomerular filtration rate decreased
  9. Protein total increased
  10. Dizziness

male:

  1. Dizziness
  2. Fatigue (feeling of tiredness)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Diarrhoea
  5. Dry mouth
  6. Dyspepsia (indigestion)
  7. Dyspnoea (difficult or laboured respiration)
  8. Ear infection
  9. Headache (pain in head)
  10. Influenza

What are the common drug interactions of Filspari and Jardiance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Fatigue (feeling of tiredness)
  2. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  3. Glomerular filtration rate decreased
  4. Migraine (headache)
  5. Protein total increased
  6. Blood pressure increased
  7. Chills (felling of cold)
  8. Diarrhoea
  9. Dizziness
  10. Dry mouth

30-39:

  1. Decreased appetite
  2. Headache (pain in head)
  3. Nervousness
  4. Poor quality sleep
  5. Fatigue (feeling of tiredness)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Migraine (headache)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Chest discomfort
  10. Dyspnoea (difficult or laboured respiration)

40-49:

  1. Dizziness
  2. Multiple allergies (allergy to multiple agents)
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Orthostatic hypertension (a medical condition consisting of a sudden increase in blood pressure when a person stands up)
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  7. Muscle spasms (muscle contraction)

50-59:

  1. Anxiety
  2. Dizziness
  3. Influenza

60+:

n/a

What are the existing conditions these people have? *

  1. Iga Nephropathy (kidney disease- condition prevents the kidneys from filtering waste): 14 people, 87.50%
  2. Chronic Kidney Disease: 4 people, 25.00%
  3. Haematuria (presence of blood in urine): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Filspari and Jardiance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Filspari and Jardiance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Filspari:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Jardiance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Filspari and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Jardiance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sparsentan and empagliflozin (the active ingredients of Filspari and Jardiance, respectively), and Filspari and Jardiance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: